Come up with a name for your new list and we'll add to it:
Somaxon Pharmaceuticals raised a round of funding on December 11, 2012. Investors include
Pernix Therapeutics Holdings.
Somaxon Pharmaceuticals is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary products and late-stage product candidates for the treatment…